THE CLINICAL SIGNIFICANCE OF NON-INVASIVE DIAGNOSTIC METHODS (FIBROSCAN AND BIOMARKERS) IN THE EARLY DETECTION OF LIVER PATHOLOGIES

Early detection of liver diseases remains a major challenge in modern clinical practice due to the asymptomatic nature of many hepatic conditions at initial stages. This article explores the clinical significance of non-invasive diagnostic methods, particularly FibroScan (transient elastography) and serum biomarkers, in identifying liver pathologies at early stages. The study highlights their diagnostic accuracy, advantages over invasive procedures such as liver biopsy, and their role in improving patient outcomes. Special attention is given to their applicability in chronic liver diseases, including fibrosis, cirrhosis, and non-alcoholic fatty liver disease.